Adial Pharmaceuticals
ADIL
#10837
Rank
โ‚ฌ12.08 M
Marketcap
4,60ย โ‚ฌ
Share price
36.12%
Change (1 day)
1,667.28%
Change (1 year)

Earnings for Adial Pharmaceuticals (ADIL)

Earnings in 2026 (TTM): -โ‚ฌ50.53 Million

According to Adial Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ7.28 Million, an increase over its 2024 earnings that were of -โ‚ฌ12.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adial Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ50.53 Million594.85%
2025 -โ‚ฌ7.28 Million-39.56%
2024 -โ‚ฌ12.04 Million88.48%
2023 -โ‚ฌ6.39 Million-39.45%
2022 -โ‚ฌ10.55 Million-40.76%
2021 -โ‚ฌ17.8 Million79.17%
2020 -โ‚ฌ9.94 Million26.79%
2019 -โ‚ฌ7.84 Million-26.14%
2018 -โ‚ฌ10.61 Million920.78%
2017 -โ‚ฌ1.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.97 Million-96.26% Bahamas
NRC Health
NRC
โ‚ฌ13.48 M-125.59%๐Ÿ‡บ๐Ÿ‡ธ USA